Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 11, 2016

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2027

Conditions
Multiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-CellHodgkin DiseaseNon-Small Cell Lung Cancer
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH